119 related articles for article (PubMed ID: 24777583)
1. Diagnostic nanoparticle targeting of the EGF-receptor in complex biological conditions using single-domain antibodies.
Zarschler K; Prapainop K; Mahon E; Rocks L; Bramini M; Kelly PM; Stephan H; Dawson KA
Nanoscale; 2014 Jun; 6(11):6046-56. PubMed ID: 24777583
[TBL] [Abstract][Full Text] [Related]
2. ⁹⁹mTc-labeled single-domain antibody EG2 in targeting epidermal growth factor receptor: an in-vitro and mouse model in-vivo study.
Li C; Wen B; Wang L; Feng H; Xia X; Ding Z; Gao B; Zhang Y; Lan X
Nucl Med Commun; 2015 May; 36(5):452-60. PubMed ID: 25591074
[TBL] [Abstract][Full Text] [Related]
3. In vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor.
Krüwel T; Nevoltris D; Bode J; Dullin C; Baty D; Chames P; Alves F
Sci Rep; 2016 Feb; 6():21834. PubMed ID: 26912069
[TBL] [Abstract][Full Text] [Related]
4. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments.
Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V
J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306
[TBL] [Abstract][Full Text] [Related]
5. Pointing in the Right Direction: Controlling the Orientation of Proteins on Nanoparticles Improves Targeting Efficiency.
Yong KW; Yuen D; Chen MZ; Porter CJH; Johnston APR
Nano Lett; 2019 Mar; 19(3):1827-1831. PubMed ID: 30773887
[TBL] [Abstract][Full Text] [Related]
6. Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging.
Massa S; Xavier C; De Vos J; Caveliers V; Lahoutte T; Muyldermans S; Devoogdt N
Bioconjug Chem; 2014 May; 25(5):979-88. PubMed ID: 24815083
[TBL] [Abstract][Full Text] [Related]
7. High transfection efficiency of quantum dot-antisense oligonucleotide nanoparticles in cancer cells through dual-receptor synergistic targeting.
Zhang MZ; Li C; Fang BY; Yao MH; Ren QQ; Zhang L; Zhao YD
Nanotechnology; 2014 Jun; 25(25):255102. PubMed ID: 24896735
[TBL] [Abstract][Full Text] [Related]
8. Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dots.
Ramos-Gomes F; Bode J; Sukhanova A; Bozrova SV; Saccomano M; Mitkovski M; Krueger JE; Wege AK; Stuehmer W; Samokhvalov PS; Baty D; Chames P; Nabiev I; Alves F
Sci Rep; 2018 Mar; 8(1):4595. PubMed ID: 29545609
[TBL] [Abstract][Full Text] [Related]
9. Generation of single-domain antibody multimers with three different self-associating peptides.
Wang L; Liu X; Zhu X; Wang L; Wang W; Liu C; Cui H; Sun M; Gao B
Protein Eng Des Sel; 2013 Jun; 26(6):417-23. PubMed ID: 23538432
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of ligand-EGFR interactions: a platform for screening targeting molecules.
Kuo WT; Lin WC; Chang KC; Huang JY; Yen KC; Young IC; Sun YJ; Lin FH
PLoS One; 2015; 10(2):e0116610. PubMed ID: 25723471
[TBL] [Abstract][Full Text] [Related]
11. Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein.
Miao Z; Ren G; Liu H; Jiang L; Cheng Z
Bioconjug Chem; 2010 May; 21(5):947-54. PubMed ID: 20402512
[TBL] [Abstract][Full Text] [Related]
12. RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer.
Yu F; Wang Y; Xiao Y; He Y; Luo C; Duan D; Li C; Xu S; Xiang T
Mol Immunol; 2014 May; 59(1):100-9. PubMed ID: 24534066
[TBL] [Abstract][Full Text] [Related]
13. Sortase A-mediated site-specific labeling of camelid single-domain antibody-fragments: a versatile strategy for multiple molecular imaging modalities.
Massa S; Vikani N; Betti C; Ballet S; Vanderhaegen S; Steyaert J; Descamps B; Vanhove C; Bunschoten A; van Leeuwen FW; Hernot S; Caveliers V; Lahoutte T; Muyldermans S; Xavier C; Devoogdt N
Contrast Media Mol Imaging; 2016 Sep; 11(5):328-339. PubMed ID: 27147480
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20.
Krasniqi A; Bialkowska M; Xavier C; Van der Jeught K; Muyldermans S; Devoogdt N; D'Huyvetter M
N Biotechnol; 2018 Oct; 45():69-79. PubMed ID: 29574274
[TBL] [Abstract][Full Text] [Related]
15. Self-Assembling VHH-Elastin-Like Peptides for Photodynamic Nanomedicine.
Pille J; van Lith SA; van Hest JC; Leenders WP
Biomacromolecules; 2017 Apr; 18(4):1302-1310. PubMed ID: 28269985
[TBL] [Abstract][Full Text] [Related]
16. Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer.
Chen F; Ma K; Madajewski B; Zhuang L; Zhang L; Rickert K; Marelli M; Yoo B; Turker MZ; Overholtzer M; Quinn TP; Gonen M; Zanzonico P; Tuesca A; Bowen MA; Norton L; Subramony JA; Wiesner U; Bradbury MS
Nat Commun; 2018 Oct; 9(1):4141. PubMed ID: 30297810
[TBL] [Abstract][Full Text] [Related]
17. Tuning nanoparticle uptake: live-cell imaging reveals two distinct endocytosis mechanisms mediated by natural and artificial EGFR targeting ligand.
Mickler FM; Möckl L; Ruthardt N; Ogris M; Wagner E; Bräuchle C
Nano Lett; 2012 Jul; 12(7):3417-23. PubMed ID: 22632479
[TBL] [Abstract][Full Text] [Related]
18. Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells.
Liu CW; Lin WJ
J Drug Target; 2013 Sep; 21(8):776-86. PubMed ID: 23829387
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-Hydrazinonicotinamide epidermal growth factor-polyethylene glycol-quantum dot imaging allows quantification of breast cancer epidermal growth factor receptor expression and monitors receptor downregulation in response to cetuximab therapy.
Jung KH; Choe YS; Paik JY; Lee KH
J Nucl Med; 2011 Sep; 52(9):1457-64. PubMed ID: 21849406
[TBL] [Abstract][Full Text] [Related]
20. Engineering the Orientation, Density, and Flexibility of Single-Domain Antibodies on Nanoparticles To Improve Cell Targeting.
Yong KW; Yuen D; Chen MZ; Johnston APR
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5593-5600. PubMed ID: 31917547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
